About: A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 26 February 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2003 (uk) article scientifique publié en 2003 (fr) im Februar 2003 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 2003 (ast) scientific article published on 26 February 2003 (en)
publication date	wds:Q73201224-EB4B8895-E9D9-4B59-B7B0-9C6E7F67666F
publication date	2003-02-26 00:00:00Z (xsd:dateTime)
exact match	wds:Q73201224-A80B5159-3288-4C70-9B6E-F66A5A816BBD
exact match	https://scigraph.springernature.com/pub.10.1007/s00262-002-0343-x
author name string	wds:Q73201224-14413026-9131-4713-9131-B14F23BFCD7A wds:Q73201224-2D9FA030-417C-4E01-8DA4-6F4657E48262 wds:Q73201224-35A3456D-2EEE-44F9-BCB2-0A575DD02C78 wds:Q73201224-964F0CBC-2077-4A09-9C72-C05628BB3CAD wds:Q73201224-B31FFF26-5E26-4299-9695-B83142C7749A wds:Q73201224-CBBBC1CD-4F22-4732-A0B9-5491A610A6A9 wds:Q73201224-D5125DBB-E3A6-488D-AC56-16FFF8E32A60 wds:Q73201224-ECFB6C49-BFF7-41F6-9BF0-30D5D8D6BADC
author name string	Stephen Y Chan Neil J Finkler Robert E Coleman Alan N Gordon Mark S Berger Matthew L Sherman James B Hall Catharine B Eten
rdfs:label	A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma (en) A phase 2 study of the cytotoxic immunoconjugate CMB-401 (nl)
skos:prefLabel	A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma (en) A phase 2 study of the cytotoxic immunoconjugate CMB-401 (nl)
name	A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma (en) A phase 2 study of the cytotoxic immunoconjugate CMB-401 (nl)
title	wds:Q73201224-2395CA8A-5B6E-4D38-BDAA-116EF4E55635
title	A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma (en)
page(s)	wds:Q73201224-665D2343-DE55-460C-8FDB-0212CBEC53F2
page(s)	243-248
instance of	wds:Q73201224-BB1D79C4-39AD-4484-AAF3-11DB063A8273
instance of	scholarly article
main subject	wds:Q73201224-F872E7CF-F006-46AA-80B1-F9735DA9528E
main subject	ovarian carcinoma
PubMed ID	wds:Q73201224-F383F62D-D25A-4BAF-B8DF-C38D8EB80438
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12669249
PubMed ID	12669249
published in	wds:Q73201224-2F79BFD5-65BB-450C-A5A6-E2858B395E97
published in	Cancer Immunology, Immunotherapy
issue	wds:Q73201224-3845A040-52B3-4880-AEC3-3EEF0A94A5B4
volume	wds:Q73201224-7DABAD10-64C9-4B2A-BB83-507C507DA9C8
issue	4
volume	52
DOI	wds:Q73201224-03F1CC21-50D5-44C4-B935-FCD9DAB40016
DOI	http://dx.doi.org/10.1007/S00262-002-0343-X
DOI	10.1007/S00262-002-0343-X
Dimensions Publication ID	wds:Q73201224-7C7FBF1F-70BB-4EDE-8B0E-96E12DC4A472
Dimensions Publication ID	1075261714
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73201224
is cites work of	CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers Use of antibodies and immunoconjugates for the therapy of more accessible cancers Computational selection of antibody-drug conjugate targets for breast cancer. DNA damaging agent-based antibody-drug conjugates for cancer therapy Improved Chemical Strategies for the Targeted Therapy of Cancer
is cites work of	wds:Q44619969-C9FFCCB9-E8D1-4E04-B804-7EFD0F00B7AC wds:Q35980938-6DE8CB01-0225-4941-B8A9-88BEC26D5055 wds:Q37174938-20FA5FFA-5067-432D-96B2-4B8F9E1CAFF9 wds:Q57192403-C623EDA9-C6B4-459C-A81B-338D5C6AFC19 wds:Q43262208-DE2D20B7-A49B-4EF4-A1E7-49B81527B7D0 wds:Q36771856-F4A033CB-9D1E-401A-A9A1-FD6FAAEC3232

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software